Safety of L-proline as a stabilizer for immunoglobulin products.

Hagan JB, Wasserman RL, Baggish JS, Spycher MO, Berger M, Shashi V, Lohrmann E, Sullivan KE. Safety of L-proline as a stabilizer for immunoglobulin products. Expert Rev Clin Immunol. 2012 Feb; 8(2):169-78.

View in: PubMed

subject areas

Animals
Chromosome Deletion
Chromosomes, Human, Pair 22
Drug Stability
Excipients
Genetic Diseases, Inborn
Humans
Immunoglobulin G
Immunoglobulins, Intravenous
Proline

authors with profiles

Kathleen Sullivan, APRN, PMHCNS-BC

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support